HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Ruben Niesvizky Selected Research

Ruben Niesvizky Research Topics

Disease

27	Multiple Myeloma 01/2010 - 03/2002
5	Neoplasms (Cancer) 01/2010 - 03/2002
4	Lymphoma (Lymphomas) 01/2009 - 02/2006
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2008 - 08/2005
3	Disease Progression 07/2009 - 09/2002
3	Thrombosis (Thrombus) 07/2008 - 09/2002
2	Melanoma (Melanoma, Malignant) 01/2010 - 07/2005
2	Testicular Neoplasms (Testicular Cancer) 01/2010 - 07/2005
2	Venous Thromboembolism 01/2010 - 11/2007
2	Thromboembolism 01/2010 - 12/2007
2	Fatigue 08/2009 - 04/2009
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2008 - 03/2008
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2003 - 09/2002
1	Diarrhea 08/2009
1	Fever (Fevers) 04/2009
1	Nausea 04/2009
1	Hematologic Neoplasms (Hematological Malignancy) 02/2009
1	Hodgkin Disease (Hodgkin's Disease) 01/2009
1	Acute Promyelocytic Leukemia 07/2008
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2008
1	Hemorrhage 07/2008
1	Neutropenia 11/2007
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2005
1	Monoclonal Gammopathy of Undetermined Significance 07/2005
1	Compression Fractures (Compression Fracture) 09/2004
1	Bone Resorption 04/2003
1	Neurologic Manifestations (Neurological Manifestations) 09/2002

Drug/Important Bio-Agent (IBA)

13	Dexamethasone (Maxidex)FDA LinkGeneric 01/2010 - 03/2002
10	lenalidomide (CC 5013)FDA Link 01/2010 - 09/2007
5	bortezomib (Velcade)FDA Link 08/2009 - 11/2005
5	Thalidomide (Thalomid)FDA Link 08/2009 - 09/2002
5	Clarithromycin (Biaxin)FDA LinkGeneric 07/2008 - 09/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2008 - 03/2008
2	AntigensIBA 01/2010 - 07/2005
2	Etoposide (VP 16)FDA LinkGeneric 05/2008 - 03/2008
2	Prednisone (Sone)FDA LinkGeneric 05/2008 - 03/2008
2	Procarbazine (Matulane)FDA Link 05/2008 - 03/2008
2	rituximab (Mabthera)FDA Link 04/2008 - 08/2005
2	Monoclonal AntibodiesIBA 04/2008 - 08/2005
2	Cyclin-Dependent Kinase 4IBA 08/2006 - 12/2005
2	IodineIBA 02/2006 - 08/2005
1	Proteins (Proteins, Gene)IBA 01/2010
1	vorinostat (suberoylanilide hydroxamic acid)FDA Link 08/2009
1	tranilast (N 5')IBA 08/2009
1	thymidine 5'-triphosphate (TTP)IBA 04/2009
1	oblimersen (G3139)IBA 04/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2009
1	milatuzumabIBA 01/2009
1	AutoantibodiesIBA 07/2008
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2007
1	6- acetyl- 8- cyclopentyl- 5- methyl- 2- (5- piperazin- 1- ylpyridin- 2- ylamino)- 8H- pyrido(2,3- d)pyrimidin- 7- oneIBA 08/2006
1	Cyclin D1IBA 12/2005
1	Retinoblastoma ProteinIBA 12/2005
1	CyclinsIBA 12/2005
1	Cyclin-Dependent Kinase 6IBA 12/2005
1	Cyclin D2IBA 12/2005
1	fludarabineIBA 08/2005
1	hLL2 agent (epratuzumab)IBA 08/2005
1	Messenger RNA (mRNA)IBA 07/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2005
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2005
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2005
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2005
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 04/2005
1	gallium nitrate FDA Link 04/2003

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 02/2006 - 03/2002
2	Heterologous Transplantation (Xenotransplantation) 01/2009 - 08/2006
2	Combination Drug Therapy (Combination Chemotherapy) 05/2008 - 03/2008
1	Stem Cell Transplantation 08/2009
1	Salvage Therapy 06/2009
1	Immunomodulation 12/2008
1	Hematopoietic Stem Cell Mobilization 07/2008
1	Splenectomy 04/2008
1	Radioimmunotherapy 08/2005
1	Immunotherapy 07/2005
1	Vertebroplasty 09/2004